Jay Raman, MD, Urology, Hershey, PA, Penn State Milton S. Hershey Medical Center

JayDilipRamanMDFACS

Urology Hershey, PA

Minimally Invasive Surgery, Surgical Oncology

Professor and Chief of Urology Department of Surgery Penn State Health Milton S. Hershey Medical Center

Dr. Raman is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Raman's full profile

Already have an account?

  • Office

    500 University Drive
    BMR Building, c4830F - Penn State Milton S. Hershey Medical Center
    Hershey, PA 17033
    Phone(717) 531-8848
    Fax(717) 531-4475
  • Is this information wrong?

Summary

  • Jay D. Raman, M.D. is currently Professor of Surgery and Chief of the Division of Urology at the Penn State Health Milton S. Hershey Medical Center. He received his undergraduate degree from the Massachusetts Institute of Technology (MIT) and graduated AOA from Cornell University Medical College. Dr. Raman completed his urology residency at Cornell Medical Center followed by a fellowship in Laparoscopy and Robotics at the University of Texas Southwestern Medical Center in Dallas.

    Dr. Raman’s clinical practice focuses on robotic-assisted surgery for prostate, kidney, ureteral, and adrenal cancers having completed over 2500 such cases. His basic science research centers on infectious complications following prostate needle biopsy as well biomarkers for urothelial cancer. His major clinical research efforts revolve around surgical complications as well as staging and therapy for urologic malignancies. To date, he has co-authored over 290 manuscripts, book chapters, and editorials and serves on the editorial board for 3 journals and as a reviewer for 12 journals.

    Dr. Raman is currently Chair-Elect of the American Urologic Association (AUA) Office of Education, President of the Mid-Atlantic AUA section, and Young Urology Representative to the American College of Surgeons.
  • GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma by AUAUniv

    At the conclusion of this activity, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks a

    103020PennStateHealth.mp4

    Penn State Health No Shave November 2020

    Penn State Health Urology Residency Program

    The Urology Residency is a five year program intended to develop a superb urologist who has as their primary concern the health and well-being of the patient...

    Urology Teaching Collaborative | 6/4/20 | Dr. Jay Raman: Microhematuria Evaluati

    Dr. Jay Raman from Penn State Health-Hershey's Department of Urology on Penn State Health-Hershey

    Penn State Health Cancer Treatment and Research

    Cancer is a diagnosis no one wants to hear. Fortunately, patients are living longer thanks to the advancement of treatment and research. On a special Good Day P

    5.21.2020 Urology COViD Didactics - Evaluation of the Patient with MicroHematuri

    Week 8 session 7 for Urology Collaborative Online Virtual Didactics (COViD) lecture series. Date: 5.21.2020 Topic: Evaluation of the Patient with MicroHematu...

    No Shave November 2019 - Penn State Health

    No-Shave November is a month-long journey during which participants forgo shaving and grooming in order to evoke conversation and raise cancer awareness. Pen...

    Penn State Health - THIS is Heroism.

    In the most challenging times, heroes emerge. As children our heroes wore capes and had superhuman powers. As adults, we've found that phenomenal strength, d...

    Penn State Health: No Shave November, Prostate Cancer Prevention

    During the month of November, men are asked to let their hair and beards grow to raise money and awareness in the fight against prostate cancer. On a special Go

    Mid Penn Bank, Penn State Health 'No Shave November' campaign raises $60K

    Last month, friends from Penn State Health and Mid Penn Bank teamed up to raise money and awareness for prostate cancer. On Thursday's Good Day PA, we learned t

    What are some of the risk factors of prostate cancer? Penn State Cancer Institut

    What are some of the risk factors of prostate cancer? Quick answers from our Penn State Cancer Institute experts! Dr. Jay Raman Professor & Chief, Division of U

    When should men get screened for prostate cancer? - Penn State Cancer Institute

    When should men get screened for prostate cancer? Quick answers from our Penn State Cancer Institute experts! Dr. Jay Raman Professor & Chief, Division of Urolo

    No Shave November donations to Penn State Cancer Institute

    As "No Shave November" comes to an end, Penn State Health and Mid Penn Bank share the results of a fundraising effort for prostate cancer research.

    Penn State Health: 'Movember' & Prostate Cancer

    Today is the start of "Movember." Doctors from Penn State Cancer Institute were on Good Day PA to talk about prostate cancer.

    Penn State Health: New MRI Guided Fusion Prostate Biopsy

    It's a new detection technique for Prostate Cancer. Dr. Jay Raman, Chief of Urology at Penn State Health was here to tell us all about the new technique!

    Penn State Health: Prostate Cancer Prevention and Detection Special Part 1

    In part one of this special edition of Good Day PA, we'll learn about a midstate man who discovered a rise in his PSA test numbers after being regularly tested

    The Significance of Hematuria in Urothelial Carcinoma

    Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with

    What new prostate cancer research is being done at Penn State Hershey?

    What new prostate cancer research Penn State Hershey working on? Jay D. Raman, M. D., Urologist, Penn State Cancer Institute

    What happens after being diagnosed with prostate cancer?

    Penn State Cancer Institute - What happens after being diagnosed with prostate cancer? Jay D. Raman, M. D. Urologist, Penn State Cancer Institute

    Dr. Raman on Hematuria in Urothelial Cancer

    Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with

    AUAA... Episode 2 - Prostate Cancer - Penn State Health Milton S. Hershey Medica

    Dr. Jay Raman, Chief, Division of Urology at Penn State Health answers questions in a Facebook Live interview. Answering when some men should start getting scre

    Behind the Hands - Penn State Hershey Cancer Institute - Jay Raman, M.D.

    Penn State Hershey - when choosing a surgeon, the technique - whether robotic or open surgery - doesn't matter as much as the experience of the surgeon and his

Skills & Expertise

  • Laparoscopy, Ureteroscopy, Nephrectomy, Prostatectomy, Urologic oncology, Minimally invasive urologic surgery, Biopsies, Hydronephrosis, Immunohistochemistry, Lymph node excision, Logistic models, Combined modality therapy, Adrenal disease, Health outcomes research, Neoplasm staging, Kidney Neoplasms, Local Neoplasm Recurrence, Prognosis, Retrospective Studies, Urologic Neoplasms

Education & Training

  • University of Texas Southwestern Medical Center Affiliated HospitalsFellowship, Minimally invasive oncology, 2007 - 2008
  • New York Presbyterian HospitalResidency, Urology, 2003 - 2007
  • New York Presbyterian HospitalResidency, General Surgery, 2001 - 2003
  • Weill Cornell Medical College of Cornell UniversityClass of 2001
  • Massachusetts Institute of TechnologyB.S., 1997

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2008 - 2022
  • TX State Medical License
    TX State Medical License 2007 - 2008
  • NY State Medical License
    NY State Medical License 2003 - Present
  • American Board of Urology Urology
  • Endourology SocietyFellowship Certification

Awards, Honors, & Recognition

  • AUA Distinguished Service Nominee Mid-Atlantic Section of AUA, 2019
  • AUA Gold Cystoscope Award Nominee Mid-Atlantic AUA Section, 2017
  • Young Urologist of the Year American Urological Association, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
    Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
  • Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell Carcinoma  
    Brian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology
  • TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma  
    Youssef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V, World J Urol, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Evaluation and management of urinary tract bleeding: from asymptomatic microhematuria to intractable hemorrhagic cystitis 
    1/1/2015
  • Upper-tract Urothelial Carcinoma: controversies and considerations 
    Washington, DC - 1/1/2015
  • Surgical management of urothelial carcinoma with squamous differentiation 
    1/1/2014
  • Join now to see all

Authored Content

  • Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018

Press Mentions

  • Many Men Ignore Testicular Cancer Symptoms for Months
    Many Men Ignore Testicular Cancer Symptoms for MonthsJuly 5th, 2016
  • Detecting and Treating Urologic Cancers with Penn State Hershey Cancer Institute
    Detecting and Treating Urologic Cancers with Penn State Hershey Cancer InstituteSeptember 8th, 2015

Grant Support

  • The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of RecurrenceUrogen Pharma Ltd2019–2021
  • The CXBladder Hematuria Clinical Utility StudyPacific Edge Biotechnologies2019–2021
  • A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of Instillation of Mitogel on Ablation of Urothelial Carcinoma Lesions in the Upper Urinary TractUrogen Pharma Ltd2017–2020
  • Multi-Institutional Study To Evaluate DNA Methylation Markers For Detection Of Primary Bladder Cancers In Urine Samples From a Cohort Of Patients With HematuriaMDXHealth Inc.2017–2019
  • Association of metabolic syndrome with pathologic characteristics of kidney cancerPenn State Kidney Cancer Fund2015–2019
  • Impact of low dose naltrexone on in vitro and in vivo prostate cancer growthKen and Bonnie Shockey Fund2014–2019
  • Molecular profiling of high risk bladder cancer to predict BCG responsivenessAlbert Foundation2016–2018
  • Nanojacket delivery of novel antibioticsPenn State Clinical Translational Science Institute (CTSI)2015–2017

Committees

  • Chair, AUA Video Education Committee 2016 - Present
  • Chair-Elect, AUA Office of Education 2020 - 2020
  • Vice Chair, AUA Video Education Committee 2014 - 2016

Research History

  • Minimally invasive surgical fellowUTSW Medical Center2007 - 2008

Professional Memberships

Hospital Affiliations